Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20091
20111
20121
20161
20171
20181
20191
20201
20211
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
AstraZeneca2
Auricula Biosciences Inc.1
Bayer1
Centocor, Inc.1
Genmab1
Kymab Limited1
NHS Greater Glasgow and Clyde1
Royal Marsden NHS Foundation Trust1
Targovax ASA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms16
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms6
Stomach Neoplasms6
Ovarian Neoplasms5
Uterine Cervical Neoplasms5
Esophageal Neoplasms4
Triple Negative Breast Neoplasms4
Lung Neoplasms3
Neoplasms3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.